<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9319162</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2572</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Opin. Neurol.</journal-id>
<journal-title-group>
<journal-title>Current opinion in neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1350-7540</issn>
<issn pub-type="epub">1473-6551</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26953849</article-id>
<article-id pub-id-type="pmc">4850909</article-id>
<article-id pub-id-type="doi">10.1097/WCO.0000000000000298</article-id>
<article-id pub-id-type="manuscript">NIHMS767281</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Developmental Neuroscience Approach to the Search for Biomarkers in Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Varcin</surname>
<given-names>Kandice J.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nelson</surname>
<given-names>Charles A.</given-names>
<suffix>III</suffix>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Laboratories of Cognitive Neuroscience, Division of Developmental Medicine, Boston Childrenâ€™s Hospital, Harvard Medical School, Boston MA USA</aff>
<aff id="A2"><label>2</label>Graduate School of Education, Harvard University, Cambridge MA USA</aff>
<author-notes>
<corresp id="cor1">Corresponding author: Charles A. Nelson III, PhD, Laboratory of Cognitive Neuroscience, 1 Autumn Street, 6<sup>th</sup> Floor, Boston, MA 02215; Phone: +1 617-355-0401; <email>charles_nelson@harvard.edu</email></corresp>
<fn fn-type="conflict" id="FN1">
<p id="P26">Conflicts of interest: K.J.V. has no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>22</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>29</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>129</lpage>
<!--elocation-id from pubmed: 10.1097/WCO.0000000000000298-->
<abstract>
<sec id="S1">
<title>Purpose of review</title>
<p id="P1">The delineation of biomarkers in autism spectrum disorder (ASD) offers a promising approach to inform precision-medicine based approaches to ASD diagnosis and treatment and to move toward a mechanistic description of the disorder. However, biomarkers with sufficient sensitivity or specificity for clinical application in ASD are yet to be realized. Here, we review recent evidence for early, low-level alterations in brain and behavior development that may offer promising avenues for biomarker development in ASD.</p>
</sec>
<sec id="S2">
<title>Recent findings</title>
<p id="P2">Accumulating evidence suggests that signs associated with ASD may unfold in a manner that maps onto the hierarchical organization of brain development. Genetic and neuroimaging evidence points towards perturbations in brain development early in life, and emerging evidence indicates that sensorimotor development may be amongst the earliest emerging signs associated with ASD, preceding social and cognitive impairment.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">The search for biomarkers of risk, prediction and stratification in ASD may be advanced through a developmental neuroscience approach that looks outside of the core signs of ASD and considers the bottom-up nature of brain development alongside the dynamic nature of development over time. We provide examples of assays that could be incorporated in studies to target low-level circuits.</p>
</sec>
</abstract>
<kwd-group>
<kwd>biomarkers</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>neurodevelopmental</kwd>
<kwd>early development</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>